February 1, 2011Biomarkers in Medicine
Functional Testing Methods for the Antiplatelet Effects of Aspirin
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Does not support routine aspirin monitoring in practice; leaves open whether outcome-linked biomarkers can be validated prospectively.
Structured PICO
I
Intervention
Functional testing methods for the antiplatelet effects of aspirin (75-325 mg/day)
Routine clinical monitoring of aspirin efficacy via platelet function testing or biomarkers is currently not recommended due to a lack of established predictive value for clinical outcomes.
Cite This Study
Schrör et al. (2011) studied this question.